This is the authors' abstract. We don't add key points for this paper.
Lercanidipine is a 1,4-dihydropyridine calcium channel blocker. For severe toxicity, treatment modalities are based on a restricted range of evidence and clinical experience. This case report describes our clinical experience regarding the treatment of Lercanidipine overdose in a 16-year-old girl. To the best of our knowledge, this is the first reported pediatric case overdose of lercanidipine.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Volkan Bayar (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: